SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Maria M. Lleo, Valentina Ghidini, Maria Carla Tafi, Francesco Castellani, Ilaria Trento, Marzia Boaretti, Detecting the presence of bacterial DNA by PCR can be useful in diagnosing culture-negative cases of infection, especially in patients with suspected infection and antibiotic therapy, FEMS Microbiology Letters, 2014, 354, 2
  2. 2
    Mitsuo Shimada, Yuji Morine, Hiroaki Nagano, Etsuro Hatano, Takashi Kaiho, Masaru Miyazaki, Toru Kono, Toshiya Kamiyama, Satoshi Morita, Junichi Sakamoto, Mitsuo Kusano, Shigetoyo Saji, Takashi Kanematsu, Masaki Kitajima, Effect of TU-100, a traditional Japanese medicine, administered after hepatic resection in patients with liver cancer: a multi-center, phase III trial (JFMC40-1001), International Journal of Clinical Oncology, 2014,

    CrossRef

  3. 3
    Michele Bartoletti, Maddalena Giannella, Paolo Caraceni, Marco Domenicali, Simone Ambretti, Sara Tedeschi, Gabriella Verucchi, Lorenzo Badia, Russell E. Lewis, Mauro Bernardi, Pierluigi Viale, Epidemiology and outcomes of bloodstream infection in patients with cirrhosis, Journal of Hepatology, 2014, 61, 1, 51

    CrossRef

  4. 4
    Manuel Romero-Gómez, Sara Montagnese, Rajiv Jalan, Hepatic encephalopathy in patients with acute decompensation of cirrhosis and acute-on-chronic liver failure, Journal of Hepatology, 2014,

    CrossRef

  5. 5
    Louise Madeleine Risør, Flemming Bendtsen, Søren Møller, Immunologic, hemodynamic, and adrenal incompetence in cirrhosis: impact on renal dysfunction, Hepatology International, 2014,

    CrossRef

  6. 6
    Bernd Schnabl, David A. Brenner, Interactions Between the Intestinal Microbiome and Liver Diseases, Gastroenterology, 2014, 146, 6, 1513

    CrossRef

  7. 7
    Taira Kuroda, Masashi Hirooka, Mitsuhito Koizumi, Hironori Ochi, Yoshiko Hisano, Kenji Bando, Bunzo Matsuura, Teru Kumagi, Yoichi Hiasa, Pancreatic congestion in liver cirrhosis correlates with impaired insulin secretion, Journal of Gastroenterology, 2014,

    CrossRef

  8. 8
    J. S. Bajaj, D. M. Heuman, P. B. Hylemon, A. J. Sanyal, P. Puri, R. K. Sterling, V. Luketic, R. T. Stravitz, M. S. Siddiqui, M. Fuchs, L. R. Thacker, J. B. Wade, K. Daita, S. Sistrun, M. B. White, N. A. Noble, C. Thorpe, G. Kakiyama, W. M. Pandak, M. Sikaroodi, P. M. Gillevet, Randomised clinical trial: Lactobacillus GG modulates gut microbiome, metabolome and endotoxemia in patients with cirrhosis, Alimentary Pharmacology & Therapeutics, 2014, 39, 10
  9. 9
    Rohit Mittal, Craig M. Coopersmith, Redefining the gut as the motor of critical illness, Trends in Molecular Medicine, 2014, 20, 4, 214

    CrossRef

  10. 10
    Eamonn M.M. Quigley, Small intestinal bacterial overgrowth, Current Opinion in Gastroenterology, 2014, 30, 2, 141

    CrossRef

  11. 11
    Nowlan Selvapatt, Arjuna Singanayagam, Julia Wendon, Charalambos Gustav Antoniades, Understanding infection susceptibility in patients with acute-on-chronic liver failure, Intensive Care Medicine, 2014, 40, 9, 1363

    CrossRef

  12. 12
    Elisabet Sánchez, Juan C. Nieto, Ana Boullosa, Silvia Vidal, Francesc J. Sancho, Giacomo Rossi, Pau Sancho-Bru, Rosa Oms, Beatriz Mirelis, Cándido Juárez, Carlos Guarner, Germán Soriano, VSL#3 probiotic treatment decreases bacterial translocation in rats with carbon tetrachloride-induced cirrhosis, Liver International, 2014, 34, 10
  13. 13
    Hitoshi Maruyama, Hidehiro Kamezaki, Takayuki Kondo, Tadashi Sekimoto, Taro Shimada, Masanori Takahashi, Hidehiro Okugawa, Osamu Yokosuka, Effects of Inferior Mesenteric Vein Flow in Patients With Cirrhosis, Clinical Gastroenterology and Hepatology, 2013, 11, 12, 1648

    CrossRef

  14. 14
    Kirsten E. Pijls, Daisy M. A. E. Jonkers, Elhaseen E. Elamin, Ad A. M. Masclee, Ger H. Koek, Intestinal epithelial barrier function in liver cirrhosis: an extensive review of the literature, Liver International, 2013, 33, 10
  15. 15
    Stelios F. Assimakopoulos, On the role of intestinal hyperpermeability in complications of cirrhosis, Liver International, 2013, 33, 3
  16. 16
    Bjørn S. Madsen, Troels Havelund, Aleksander Krag, Targeting the Gut–Liver Axis in Cirrhosis: Antibiotics and Non-Selective β-Blockers, Advances in Therapy, 2013, 30, 7, 659

    CrossRef